Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product

Clinical trial NCT05234775 · COMPLETED

Trial details

NCT number: NCT05234775
Sponsor: LIB Therapeutics LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2022-01-28
Primary completion: 2022-06-30
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.